The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

CompletedOBSERVATIONAL
Enrollment

302

Participants

Timeline

Start Date

August 10, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 31, 2021

Conditions
Coronary Artery DiseaseMyocardial Ischemia
Interventions
OTHER

No intervention

Due to observational study

Trial Locations (10)

29407

Medical University of South Carolina, Charleston

33308

Holy Cross Health, Fort Lauderdale

37232

Vanderbilt University Medical Center, Nashville

66160

University of Kansas Medical Center, Kansas City

97239

Oregon Health & Science University, Portland

Unknown

Medical University Innsbruck, Innsbruck

University of Ferrara, Ferrara

University of Milan, Milan

National Institute of Cardiology, Warsaw

06700

Institute of Arnualt Tzanck, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Medical University of South Carolina

OTHER

lead

Keya Medical

INDUSTRY